Replimune Group, Inc. (REPL)
4.76
-1.15
(-19.46%)
USD |
NASDAQ |
Apr 10, 16:00
1.75
-3.01
(-63.24%)
After-Hours: 20:00
Replimune Group Price : 4.76 for April 10, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ANI Pharmaceuticals, Inc. | 78.36 |
| Phathom Pharmaceuticals, Inc. | 12.63 |
| REGENXBIO, Inc. | 8.80 |
| Bristol Myers Squibb Co. | 58.62 |
| Organon & Co. | 8.83 |
Price Related Metrics
| PEG Ratio | -0.0952 |
| Price to Book Value | 1.867 |
| Earnings Yield | -75.26% |
| Market Cap | 393.05M |
| PEGY Ratio | -0.0952 |